What Can a Cosmeceutical Label Legally Say?

A "cosmeceutical" label promises nothing that the law can hold a company to, because U.S. law does not recognize the word at all. The Federal Food, Drug, and Cosmetic Act (FD&C Act) sorts products into cosmetics and drugs, and it allows a product to be both, but the FDA states flatly that the statute "does not recognize any such category as 'cosmeceuticals.'" What sets a product's legal status is not the jar, the price, or the ingredient list. It is the product's intended use, and intended use is read directly off the claims. Write the wrong sentence on the box and a moisturizer becomes, in the eyes of the law, an unapproved drug.

Key points#

• The FD&C Act has two categories, cosmetics and drugs, plus products that are both. There is no legal middle tier called "cosmeceutical."
• A product's category is fixed by its intended use, which the FDA infers from claims in labeling, advertising, and other promotion.
• A claim that a product changes the skin's structure or function, or treats a disease, is a drug claim, no matter how cosmetic the goal looks.
• Drug claims carry a premarket evidence and approval standard that cosmetic claims never have to meet.

A word the statute never defined#

The prefix does the selling. Attaching "pharmaceutical" to "cosmetic" suggests clinical seriousness, active biology, and results a plain cream could not deliver. Regulators simply do not play along. The FDA treats "cosmeceutical" as an industry marketing term for a cosmetic marketed as though it had drug-like benefits, and it warns that printing the word on a label grants no special standing and no relief from the rules that govern drugs. So the honest starting point is that the term describes a sales strategy, not a legal object.

The two definitions that do carry legal weight are narrow and old. A cosmetic is an article intended to cleanse, beautify, promote attractiveness, or alter the appearance, without affecting the body's structure or functions. A drug is an article intended to diagnose, cure, mitigate, treat, or prevent disease, or intended to affect the structure or any function of the body. Everything hangs on those two clauses.

Nothing stops a single product from satisfying both. The FDA's standing example is an antidandruff shampoo. It is a cosmetic because it is intended to clean the hair, and it is also a drug because it is intended to treat dandruff, which is a condition of the scalp. The bottle does not announce its dual status. The claims give it away.

Intended use is decided by the claims, not the chemistry#

Here is the part that surprises people. Two jars on your shelf can hold nearly identical formulas and still sit on opposite sides of the drug line, because the divider is language. The FDA says intended use can be established several ways: by claims in labeling, by statements in advertising or online, by other promotional material, by consumer perception, and even by an ingredient that the public already associates with a particular effect. The molecule inside is not the test. What the seller says the molecule does is the test.

The agency's anti-aging guidance turns this into a clean pair of examples. A product meant to make lines look softer just by moisturizing the skin is a cosmetic. A product meant to remove wrinkles or to raise the skin's own collagen production is making a structure or function claim, which turns it into a drug (and sometimes a device), even though the visible aim is purely cosmetic. "Smooths the look of fine lines" stays on the cosmetic side. "Rebuilds collagen from within" crosses over.

Everyday products show the same split:

• Over-the-counter retinol sold to improve the look of skin is a cosmetic. Prescription tretinoin, sold to treat acne or sun-damaged skin, is an approved drug. The active is chemically related; the claim is not.
• Sunscreen is regulated as a drug in the United States, because preventing sunburn and lowering skin-cancer risk are disease and structure or function claims. That is why sunscreens fall under an over-the-counter drug framework rather than the cosmetic rules.
• A soothing balm that "hydrates chapped lips" is a cosmetic; the same balm relabeled to "heal cold sores" is a drug.

Why the drug side sets a higher bar#

Crossing the line is not a formality. It changes what the maker must be able to prove. Cosmetics do not need FDA premarket approval of the finished product. A product that makes a drug claim is a drug, and unless qualified experts already generally recognize it as safe and effective for that labeled use, it counts as a "new drug." A new drug cannot be sold legally without an approved New Drug Application, or, for eligible product types, compliance with an over-the-counter monograph that spells out permitted ingredients and claims.

That difference cuts both ways for you. When a drug claim is lawful, it stands on a standard of adequate and well-controlled evidence for both safety and effectiveness, reviewed before the product reaches shelves, and a cosmetic claim never has to clear that bar. But plenty of products borrow drug-sounding language without ever having earned it. The FDA has sent warning letters to companies selling cosmetics with anti-wrinkle or anti-aging claims that assert effects on the structure or function of the skin, with no drug approval behind them. The sentence persuades you whether or not any review stands behind it.

What the 2022 law changed, and what it left alone#

Recent reform is easy to overstate. The Modernization of Cosmetics Regulation Act of 2022 added real obligations for cosmetic makers, including facility registration, product listing, safety substantiation, and adverse-event reporting. What it did not do matters just as much. It did not invent a cosmeceutical category, and it did not require premarket approval for cosmetics the way the drug pathway does. The two-box structure, and the single claim that carries a product from one box to the other, still runs the system.

How to read a jar for yourself#

The steady way to read any product marketed to you as a cosmeceutical is to sort its claims into two piles. Put every statement about how the skin looks or feels ("reduces the appearance of," "hydrates," "softens") in the cosmetic pile; those carry no premarket evidence requirement. Put every statement about what the product does inside the skin ("stimulates collagen," "repairs," "regenerates," "treats") in the drug pile. For anything in the drug pile, the fair question you can ask is whether the product is actually an approved or monograph-compliant drug, or an unapproved one dressed as a cosmetic. And keep one distinction in view: a study reporting a measurable biological effect describes what happened in a specific group under specific conditions. That is not the same as a marketing claim, and it is not the same as FDA approval of that claim.